ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Evonik Industries has agreed to sell its U.S. and Canadian cyanide business to private equity company Oaktree Capital Management for an undisclosed sum. The business, part of Evonik's CyPlus subsidiary, includes a sodium cyanide terminal, a lab, and a 50% share in Cyanco, a joint venture with Nevada Chemicals that operates a sodium cyanide plant in Winnemucca, Nev. At the same time, Oaktree is acquiring Nevada Chemicals for about $94 million; the company's main asset is its half-share in Cyanco. Evonik says it will keep CyPlus plants in Germany and Belgium and focus them on emerging markets. Sodium cyanide is used to extract gold from ore.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X